- Home
- HALO vs CHH Comparison
HALO vs CHH Comparison
Compare HALO & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- CHH
- Stock Information
- Founded
- HALO 1998
- CHH 1939
- Country
- HALO United States
- CHH United States
- Employees
- HALO N/A
- CHH N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- CHH Hotels/Resorts
- Sector
- HALO Health Care
- CHH Consumer Discretionary
- Exchange
- HALO Nasdaq
- CHH Nasdaq
- Market Cap
- HALO 6.4B
- CHH 6.8B
- IPO Year
- HALO N/A
- CHH 1997
- Fundamental
- Price
- HALO $49.00
- CHH $149.68
- Analyst Decision
- HALO Buy
- CHH Hold
- Analyst Count
- HALO 9
- CHH 11
- Target Price
- HALO $61.11
- CHH $129.00
- AVG Volume (30 Days)
- HALO 2.3M
- CHH 381.5K
- Earning Date
- HALO 10-31-2024
- CHH 11-04-2024
- Dividend Yield
- HALO N/A
- CHH 0.77%
- EPS Growth
- HALO 61.71
- CHH N/A
- EPS
- HALO 3.02
- CHH 5.17
- Revenue
- HALO $947,355,000.00
- CHH $779,010,000.00
- Revenue This Year
- HALO $23.36
- CHH $109.47
- Revenue Next Year
- HALO $15.15
- CHH $3.20
- P/E Ratio
- HALO $16.21
- CHH $28.93
- Revenue Growth
- HALO 21.35
- CHH 3.06
- 52 Week Low
- HALO $33.15
- CHH $108.91
- 52 Week High
- HALO $65.53
- CHH $150.36
- Technical
- Relative Strength Index (RSI)
- HALO 43.09
- CHH 73.29
- Support Level
- HALO $42.01
- CHH $143.91
- Resistance Level
- HALO $46.20
- CHH $147.05
- Average True Range (ATR)
- HALO 2.76
- CHH 2.88
- MACD
- HALO -1.08
- CHH 0.19
- Stochastic Oscillator
- HALO 34.74
- CHH 94.06
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About CHH Choice Hotels International Inc.
As of Dec. 31, 2023, Choice Hotels operated 633,000 rooms across 15 brands addressing the economy and midscale segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total domestic rooms), while Ascend and Cambria (7% of total domestic rooms) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added around 70,000 rooms. Franchises account for 100% of total revenue, and the United States represent 79% of total rooms in 2023.